Clinical Trial Update: Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating patient-controlled anxiolysis using dexmedetomidine for burn-care dressing changes; study completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Burns

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Ohio State University | Conditions: Anxiety, Burns | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-14